L-Asparaginase Exerts Neuroprotective Effects in an SH-SY5Y-A53T Model of Parkinson’s Disease by Regulating Glutamine Metabolism
Background: Parkinson’s disease (PD) is the second most common neurodegenerative disease worldwide and involves deficiencies in alpha-synuclein (α-Syn) degradation. Effective therapeutic strategies for PD are urgently needed. L-asparaginase (L-ASNase) has been developed for therapeutic applications...
Main Authors: | Qingxi Zhang, Yuyuan Gao, Jiahui Zhang, You Li, Jianing Chen, Rui Huang, Guixian Ma, Limin Wang, Yuhu Zhang, Kun Nie, Lijuan Wang |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2020-09-01
|
Series: | Frontiers in Molecular Neuroscience |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fnmol.2020.563054/full |
Similar Items
-
Implication de la glutamine dans l’activation de mTORC1 dans les leucémies aiguës myéloïdes et inhibition ciblée
by: Willems, Lise
Published: (2012) -
Chemical modification of asparagine and asparaginase : evaluation of asparagine analogs, reductively methylated asparaginase and polyethylene glycol-asparaginase conjugate as therapeutic agents /
by: Chow, Wen-Shiung
Published: (1981) -
Human L-asparaginase
by: Croxtall, J. D.
Published: (1985) -
L-asparaginase: New about Well-Known Drug
by: Yuliya S. Korkina, et al.
Published: (2020-07-01) -
Physiology of L-asparaginase synthesis by Escherichia coli
by: Barnes, Wayne Riley
Published: (1979)